Trial Profile
A prospective, observational, efficacy and safety study of capecitabine as maintenance treatment after first-line chemotherapy using oxaliplatin and capecitabine in patients with advanced gastric adenocarcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 04 Nov 2015 New trial record